Drug Safety

Is There an Increased Risk of Stroke Associated with Oral Contraceptives?
pp. 467-473(7)
Authors: Zeitoun K.; Carr B.R.

Lymphoma in Patients with Rheumatoid Arthritis: What is the Evidence of a Link with Methotrexate?
pp. 475-487(13)
Authors: Georgescu L.; Paget S.A.

A Risk-Benefit Assessment of Metformin in Type 2 Diabetes Mellitus
pp. 489-503(15)
Authors: Howlett H.C.S.; Bailey C.J.

A Preliminary Risk-Benefit Assessment of Latanoprost and Unoprostone in Open-Angle Glaucoma and Ocular Hypertension
pp. 505-514(10)
Authors: Eisenberg D.L.; Camras C.B.

Adverse Skin Reactions to Low Molecular Weight Heparins: Frequency, Management and Prevention
pp. 515-525(11)
Authors: Wütschert R.; Piletta P.; Bounameaux H.

Prophylaxis and Treatment of NSAID-Induced Gastroduodenal Disorders
pp. 527-543(17)
Authors: La Corte R.; Caselli M.; Castellino G.; Bajocchi G.; Trotta F.

Predictors and Timing of Adverse Experiences During Transdermal Nicotine Therapy
pp. 545-555(11)
Authors: Gourlay S.G.; Forbes A.; Marriner T.; McNeil J.J.